Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).
about
A method for identification and analysis of non-overlapping myeloid immunophenotypes in humansStrategies for improving the reporting of human immunophenotypes by flow cytometry.MDSCs: the final frontier of the microenvironment in CLL?Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphomaIncreased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patientsThe monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions.Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses.Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia.Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages.Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia.Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance.Immune monitoring using the predictive power of immune profilesChronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib.Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
P2860
Q27310807-10E048B6-5E5D-4BDF-B7DE-58C6CE584953Q33822690-1D38B5FC-B447-4B63-9598-055D9E44A3C9Q33987027-D000AC4F-259B-44EC-BA67-1899CDE66DA0Q34016867-A6B5A4B4-99EE-48B7-8B08-59ADE1971999Q35100546-B8BC94EF-9075-4830-99AA-2EED6F870374Q35569491-127735FA-7FF5-4A8E-B1BE-68CACB1CF026Q35921894-B31C5E9B-D306-48F6-A4FC-1E71AF2C011EQ35965142-FBCA6749-5283-44CA-8DB8-5FCEF8A1898AQ36967153-57758E4E-A031-4DE0-A554-78EFC161CF75Q37362596-CE18A8A0-7C13-43C4-B84C-407684B83304Q38049970-630AA1F2-CAD7-45AF-B149-3CDAD6831432Q38207587-7AC21785-85E4-4BA3-A260-7A46C66B4D95Q38911219-8A3426E9-D873-40B7-9CF0-F4B9EF8A551DQ38970811-DD5A5B1A-9674-4AC4-96D9-BBD6D267175BQ39142960-8BEE641D-FDF4-4AF2-989B-124DFDEF83CDQ39423479-76830428-DF77-41D6-8C18-0F6C5C2A91CBQ40369611-A99577C4-4A82-474E-B737-17D8729B6578Q40551962-74123748-EB9A-4D8D-968F-270DD454DCEBQ41592583-51D260CB-042A-4BD6-B935-20CD74A5196DQ41684399-1E9A0362-BF7C-4F85-A2F5-5A3F4DB48C72Q46011813-6B300E7B-8458-4E5F-9B22-A7916DB294C7Q48154447-0BFAA40C-8EF0-4B61-AC63-D649FAB78EA5Q57138311-73551431-64F5-4104-A15E-C1359FE2224D
P2860
Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@ast
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@en
type
label
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@ast
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@en
prefLabel
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@ast
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@en
P2093
P2860
P1476
Association of an increased fr ...... c lymphocytic leukaemia (CLL).
@en
P2093
Allan B Dietz
Clive S Zent
Dennis A Gastineau
Michael P Gustafson
Roshini S Abraham
Wenting Wu
P2860
P304
P356
10.1111/J.1365-2141.2011.08902.X
P407
P577
2011-11-03T00:00:00Z